Cogent Biosciences, Inc. UMRX

Set alert

Price alert · UMRX

All alert types

No live quote for UMRX yet.

Open
2.38
Prev close
2.34
Mkt cap
73.23M
Vol
124.65K
Avg vol
519.23K
P/E
0.00
Div yield
0.00%
More statistics
Low
2.32
High
2.40
Forward P/E
-11.75
Beta
0.00
Dividend
0.00
Ex-div date
50-d avg
11.65
200-d avg
6.15
1y target
5.00

MAX chart

Chart tools
Interval

Chart is warming up

The all-time price history for UMRX has not been loaded yet. Try again in a moment.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 5.00
Target (low)
4.00
Target (mean)
5.00
Target (high)
6.00
Ratings (0m) 4 3 buy · 1 hold · 0 sell
  • Strong buy1
  • Buy2
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 4
  • 1 month ago 2
  • 2 months ago 2
  • 3 months ago 4

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

UMRX analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.19-0.34 – -0.04-0.39+51.3%00.0%2
Next quarter-0.04-0.05 – -0.040.07-157.1%00.0%2
Current year-0.54-0.83 – -0.25-1.04+48.1%7.58M-66.3%2
Next year-0.20-0.25 – -0.16-0.54+63.0%00.0%2

Upgrades and downgrades

The latest rating changes

UMRX analyst upgrades and downgrades
DateFirmActionFromTo
Oct 1, 2020JefferiesInitiated—Buy
Jul 6, 2020WedbushUpgradeNeutralOutperform
Mar 26, 2020H.C. WainwrightMaintained—Buy
Mar 3, 2020WedbushDowngradeOutperformNeutral
Mar 2, 2020Morgan StanleyDowngradeOverweightEqual-Weight
Nov 26, 2019Morgan StanleyMaintained—Overweight
Feb 25, 2019Cowen & Co.Initiated—Market Perform
Dec 19, 2018H.C. WainwrightInitiated—Buy
Oct 10, 2018Morgan StanleyMaintainedOverweightOverweight
Aug 13, 2018WedbushMaintainedOutperformOutperform
Apr 22, 2018WedbushInitiated—Outperform
Apr 22, 2018Morgan StanleyInitiated—Overweight
Apr 22, 2018Cowen & Co.Initiated—Market Perform
Apr 22, 2018SunTrust Robinson HumphreyInitiated—Buy